These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17017408)

  • 1. Leprosy blindness in Nepal.
    Gupta HR; Shakya S; Shah M; Pradhan HM
    Nepal Med Coll J; 2006 Jun; 8(2):140-2. PubMed ID: 17017408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular findings in leprosy patients in Nepal in the era of multidrug therapy.
    Nepal BP; Shrestha UD
    Am J Ophthalmol; 2004 May; 137(5):888-92. PubMed ID: 15126154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia.
    Courtright P; Daniel E; Sundarrao ; Ravanes J; Mengistu F; Belachew M; Celloria RV; Ffytche T
    Lepr Rev; 2002 Sep; 73(3):225-38. PubMed ID: 12449887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of blindness and poor vision in leprosy patients.
    Yan L; Zhang G; Zheng Z; Li W; Ye G
    Chin Med J (Engl); 2003 May; 116(5):682-4. PubMed ID: 12875679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of ocular morbidity and blindness in leprosy--a three centre study in Eastern India.
    Thompson KJ; Allardice GM; Babu GR; Roberts H; Kerketta W; Kerketta A
    Lepr Rev; 2006 Jun; 77(2):130-40. PubMed ID: 16895069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular manifestation in treated multibacillary Hansen's disease.
    Parikh R; Thomas S; Muliyil J; Parikh S; Thomas R
    Ophthalmology; 2009 Nov; 116(11):2051-7.e1. PubMed ID: 19766316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular impairments in an impairment survey of leprosy-affected persons in Nepal.
    Knuuttila JP; van Brakel WH; Anderson AM
    Indian J Lepr; 1998; 70(1):93-6. PubMed ID: 9598409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in ocular leprosy.
    Samanta SK; Das D
    Indian J Lepr; 2007; 79(2-3):135-50. PubMed ID: 18085171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular findings in leprosy patients in Nigeria.
    Nwosu SN; Nwosu MC
    East Afr Med J; 1994 Jul; 71(7):441-4. PubMed ID: 7828497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
    Schreuder PA
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of blindness in leprosy and the role of the Vision 2020 Programme.
    Hogeweg M; Keunen JE
    Eye (Lond); 2005 Oct; 19(10):1099-105. PubMed ID: 16304590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with sight threatening lesions of leprosy in patients on multidrug therapy.
    Rohatgi J; Dhaliwal U; Singal A
    J Indian Med Assoc; 2004 Jun; 102(6):297-8, 300, 302-3. PubMed ID: 15636037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deformity incidence in leprosy patients treated with multidrug therapy.
    Rao PS; Subramanian M; Subramanian G
    Indian J Lepr; 1994; 66(4):449-54. PubMed ID: 7714354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of disabling ocular complications of leprosy: a global study.
    Ffytche TJ
    Indian J Lepr; 1998; 70(1):49-59. PubMed ID: 9598405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of ocular complications in leprosy.
    Prasad VN; Narain M; Mukhija RD; Bist HK; Khan MM
    Indian J Lepr; 1984; 56(2):241-50. PubMed ID: 6548493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the magnitude of ocular complications from leprosy: problems of methodology.
    Courtright PD
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):566-73. PubMed ID: 3221113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of ocular complications of leprosy in institutionalized patients in NWFP Pakistan.
    Khan T; Awan AA; Kazmi HS; Shah AA; Muhammad S; Muhammad S
    J Ayub Med Coll Abbottabad; 2002; 14(4):29-33. PubMed ID: 12688099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
    Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
    Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular leprosy in Nigeria: a survey of an Eku leprosorium.
    Waziri-Erameh MJ; Omoti AE
    Trop Doct; 2006 Jan; 36(1):27-8. PubMed ID: 16483426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.